Benzinga's Top Upgrades, Downgrades For September 15, 2017

Top Upgrades

• JP Morgan upgraded Southwest Airlines Co. LUV from Neutral to Overweight. Southwest shares gained 1.09 percent to $54.94 in pre-market trading.
• Bank of America upgraded Bemis Company, Inc. BMS from Underperform to Neutral. Bemis shares fell 0.72 percent to close at $46.72 on Thursday.
• Longbow Research upgraded The Wendy's Company WEN from Neutral to Buy. Wendy's shares rose 2.30 percent to $15.58 in pre-market trading.
• Deutsche Bank upgraded First Solar, Inc. FSLR from Hold to Buy. First Solar shares gained 2.70 percent to $49.74 in pre-market trading.
• Bernstein upgraded Encana Corporation ECA from Market Perform to Outperform. Encana shares rose 0.67 percent to $10.52 in pre-market trading.
• HSBC upgraded Morgan Stanley MS from Hold to Buy. Morgan Stanley shares rose 0.45 percent to close at $46.43 on Thursday.
• Analysts at Jefferies upgraded West Pharmaceutical Services, Inc. WST from Hold to Buy. West Pharmaceutical shares gained 0.80 percent to close at $91.72 on Thursday.
• Piper Jaffray upgraded Henry Schein, Inc. HSIC from Neutral to Overweight. Henry Schein shares rose 3.01 percent to $83.00 in pre-market trading.

Top Downgrades

• JP Morgan downgraded United Continental Holdings Inc UAL from Overweight to Neutral. United Continental shares fell 2.37 percent to $59.80 in pre-market trading.
• Analysts at Jefferies downgraded Regency Centers Corp REG from Buy to Hold. Regency Centers shares rose 2.88 percent to close at $65.47 on Thursday.
• JP Morgan downgraded American Airlines Group Inc AAL from Overweight to Neutral. American Airlines shares fell 2.25 percent to $45.15 in pre-market trading.
• Credit Suisse downgraded Carnival Corp CCL from Outperform to Neutral. Carnival shares fell 2.15 percent to $67.26 in pre-market trading.
• Guggenheim downgraded Altice USA Inc ATUS from Buy to Neutral. Altice USA shares fell 0.71 percent to close at $29.48 on Thursday.
• Analysts at Wells Fargo downgraded Acuity Brands, Inc. AYI from Outperform to Market Perform. Acuity Brands shares fell 1.41 percent to close at $177.99 on Thursday.
• JP Morgan downgraded Spirit Airlines Incorporated SAVE from Overweight to Neutral. Spirit Airlines shares fell 1.81 percent to $34.20 in pre-market trading.
• Jefferies downgraded Retail Opportunity Investments Corp ROIC from Buy to Hold. Retail Opportunity Investments shares rose 1.27 percent to close at $19.99 on Thursday.

Top Initiations

• Macquarie initiated coverage on PepsiCo, Inc. PEP with an Outperform rating. The price target for PepsiCo is set to $125. PepsiCo shares closed at $114.19 on Thursday.
• RBC Capital initiated coverage on Celgene Corporation CELG with a Top Pick rating. The price target for Celgene is set to $176. Celgene shares closed at $140.61 on Thursday.
• Analysts at Raymond James initiated coverage of Oclaro Inc OCLR with a Strong Buy rating. The price target for Oclaro is set to $12. Oclaro shares closed at $8.77 on Thursday.
• Analysts at Cantor Fitzgerald initiated coverage on Dynavax Technologies Corporation DVAX with an Overweight rating. The price target for Dynavax Technologies is set to $24. Dynavax Technologies shares closed at $20.65 on Thursday.
• Analysts at JP Morgan initiated coverage on DowDuPont Inc DWDP with an Overweight rating. The price target for DowDuPont is set to $80. DowDuPont closed at $70.02 on Thursday.
• SunTrust Robinson Humphrey initiated coverage on Red Rock Resorts Inc RRR with a Buy rating. The price target for Red Rock Resorts is set to $26. Red Rock Resorts shares closed at $22.57 on Thursday.
• Analysts at Barclays initiated coverage on DexCom, Inc. DXCM with an Equal-Weight rating. The price target for DexCom is set to $76. DexCom shares closed at $72.35 on Thursday.
• CIBC initiated coverage on Freeport-McMoRan Inc FCX with a Sector Outperform rating. The price target for Freeport-McMoRan is set to $18. Freeport-McMoRan shares closed at $13.86 on Thursday.
• Analysts at Macquarie initiated coverage on Procter & Gamble Co PG with an Outperform rating. The price target for Procter & Gamble is set to $102. Procter & Gamble shares closed at $93.55 on Thursday.
• RBC Capital initiated coverage of Intercept Pharmaceuticals Inc ICPT with an Outperform rating. The price target for Intercept Pharmaceuticals is set to $244. Intercept Pharmaceuticals shares closed at $87.41 on Thursday.